Seemingly, GnRH antagonists are as successful as GnRH agonists and also include such advantages as shorter treatment time, lower risk of ovarian hyperstimulation syndrome, less consumption of FSH and improved patient acceptance [29,43,44]. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.